83 FR 8994 - Medicare, Medicaid, and Other Programs, Initiatives, and Priorities; Meeting of the Advisory Panel on Outreach and Education (APOE), March 21, 2018
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services Federal Register Volume 83, Issue 42 (March 2, 2018)
Centers for Medicare & Medicaid Services
Federal Register Volume 83, Issue 42 (March 2, 2018)
| Page Range | 8994-8996 | |
| FR Document | 2018-04328 |
[Federal Register Volume 83, Number 42 (Friday, March 2, 2018)] [Notices] [Pages 8994-8996] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-04328] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [CMS-7049-N] Medicare, Medicaid, and Other Programs, Initiatives, and Priorities; Meeting of the Advisory Panel on Outreach and Education (APOE), March 21, 2018 AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: This notice announces the next meeting of the Advisory Panel on Outreach and Education (APOE) (Panel) in accordance with the Federal Advisory Committee Act. The Panel advises and makes recommendations to the Secretary of the U.S. Department of Health and Human Services (HHS) and the Administrator of the Centers for Medicare & Medicaid Services (CMS) on opportunities to enhance the effectiveness of consumer education strategies concerning CMS programs, initiatives, and priorities. This meeting is open to the public. DATES: Meeting Date: Wednesday, March 21, 2018, 8:30 a.m. to 4:00 p.m. eastern daylight time (e.d.t.). Deadline for Meeting Registration, Presentations, Special Accommodations and Comments: Wednesday, March 7, 2018, 5:00 p.m. eastern standard time (e.s.t.). ADDRESSES: Meeting Location: U.S. Department of Health & Human Services, Hubert H. Humphrey Building, 200 Independence Avenue SW, Room 505A, Conference Room, Washington, DC 20201. Presentations and Written Comments: Presentations and written comments should be submitted to: Lynne Johnson, Acting Designated Federal Official (DFO), Office of Communications, Centers for Medicare & Medicaid Services, 7500 Security Boulevard, Mailstop S1-05-06, Baltimore, MD 21244-1850 or via email at [email protected]. Registration: The meeting is open to the public, but attendance is limited to the space available. Persons wishing to attend this meeting must register at the website https://www.regonline.com/apoemar2018meeting or by contacting the Acting DFO as listed in the FOR FURTHER INFORMATION CONTACT section of this notice, by the date listed in the DATES section of this notice. Individuals requiring sign language interpretation or other special accommodations should contact the Acting DFO at the address listed in the ADDRESSES section of this notice by the date listed in the DATES section of this notice. FOR FURTHER INFORMATION CONTACT: Lynne Johnson, Acting Designated Federal Official, Office of Communications, CMS, 7500 Security Boulevard, Mail Stop S1-05-06, Baltimore, MD 21244-1850, 410-786-0090, email [email protected]. Additional information about the APOE is available on the internet at: http://www.cms.gov/Regulations-and-Guidance/Guidance/FACA/APOE.html. Press inquiries are handled through the CMS Press Office at (202) 690-6145. SUPPLEMENTARY INFORMATION: I. Background The Advisory Panel for Outreach and Education (APOE) (Panel) is governed by the provisions of Federal Advisory Committee Act (FACA) (Pub. L. 92-463), as amended (5 U.S.C. Appendix 2), which sets forth standards for the formation and use of federal advisory committees. The Panel is authorized by section 1114(f) of the Social Security Act (42 U.S.C. 1314(f)) and section 222 of the Public Health Service Act (42 U.S.C. 217a). The Secretary of the U.S. Department of Health and Human Services (HHS) (the Secretary) signed the charter establishing the Citizen's Advisory Panel on Medicare Education \1\ (the predecessor to the APOE) on January 21, 1999 (64 FR 7899, February 17, 1999) to advise and make recommendations to the Secretary and the Administrator of the Centers for Medicare & Medicaid Services (CMS) on the effective implementation of national Medicare education programs, including with respect to the Medicare+Choice (M+C) program added by the Balanced Budget Act of 1997 (Pub. L. 105-33). --------------------------------------------------------------------------- \1\ We note that the Citizen's Advisory Panel on Medicare Education is also referred to as the Advisory Panel on Medicare Education (65 FR 4617). The name was updated in the Second Amended Charter approved on July 24, 2000. --------------------------------------------------------------------------- The Medicare Modernization Act of 2003 (MMA) (Pub. L. 108-173) expanded the existing health plan options and benefits available under the M+C program and renamed it the Medicare Advantage (MA) program. We have had substantial responsibilities to provide information to Medicare beneficiaries about the range of health plan options available and better tools to evaluate these options. The successful MA program implementation required CMS to consider the views and [[Page 8995]] policy input from a variety of private sector constituents and to develop a broad range of public-private partnerships. In addition, Title I of the MMA authorized the Secretary and the Administrator of CMS (by delegation) to establish the Medicare prescription drug benefit. The drug benefit allows beneficiaries to obtain qualified prescription drug coverage. In order to effectively administer the MA program and the Medicare prescription drug benefit, we have substantial responsibilities to provide information to Medicare beneficiaries about the range of health plan options and benefits available, and to develop better tools to evaluate these plans and benefits. The Affordable Care Act (Patient Protection and Affordable Care Act, Pub. L. 111-148, and Health Care and Education Reconciliation Act of 2010, Pub. L. 111-152) expanded the availability of other options for health care coverage and enacted a number of changes to Medicare as well as to Medicaid and the Children's Health Insurance Program (CHIP). Qualified individuals and qualified employers are now able to purchase private health insurance coverage through a competitive marketplace, called an Affordable Insurance Exchange (also called Health Insurance Marketplace\SM\ \2\, or Marketplace\SM\). In order to effectively implement and administer these changes, we must provide information to consumers, providers, and other stakeholders through education and outreach programs regarding how existing programs will change and the expanded range of health coverage options available, including private health insurance coverage through the Marketplace\SM\. The APOE allows us to consider a broad range of views and information from interested audiences in connection with this effort and to identify opportunities to enhance the effectiveness of education strategies concerning the Affordable Care Act. --------------------------------------------------------------------------- \2\ Health Insurance Marketplace\SM\ and Marketplace\SM\ are service marks of the U.S. Department of Health & Human Services. --------------------------------------------------------------------------- The scope of this Panel also includes advising on issues pertaining to the education of providers and stakeholders with respect to the Affordable Care Act and certain provisions of the Health Information Technology for Economic and Clinical Health (HITECH) Act enacted as part of the American Recovery and Reinvestment Act of 2009 (ARRA). On January 21, 2011, the Panel's charter was renewed and the Panel was renamed the Advisory Panel for Outreach and Education. The Panel's charter was most recently renewed on January 19, 2017, and will terminate on January 19, 2019 unless renewed by appropriate action. Under the current charter, the APOE will advise the Secretary and the Administrator on optimal strategies for the following:Developing and implementing education and outreach programs for individuals enrolled in, or eligible for, Medicare, Medicaid, and the Children's Health Insurance Program (CHIP), or coverage available through the Health Insurance Marketplace\SM\ and other CMS programs. Enhancing the federal government's effectiveness in informing Health Insurance Marketplace\SM\, Medicare, Medicaid, and CHIP consumers, issuers, providers, and stakeholders, through education and outreach programs, on issues regarding these programs, including the appropriate use of public-private partnerships to leverage the resources of the private sector in educating beneficiaries, providers, and stakeholders. Expanding outreach to vulnerable and underserved communities, including racial and ethnic minorities, in the context of Health Insurance Marketplace\SM\, Medicare, Medicaid, and CHIP education programs and other CMS programs. Assembling and sharing an information base of ``best practices'' for helping consumers evaluate health coverage options. Building and leveraging existing community infrastructures for information, counseling, and assistance. Drawing the program link between outreach and education, promoting consumer understanding of health care coverage choices, and facilitating consumer selection/enrollment, which in turn support the overarching goal of improved access to quality care, including prevention services, envisioned under the Affordable Care Act. The current members of the Panel are: Kellan Baker, Associate Director, Center for American Progress; Robert Blancato, President, National Association of Nutrition and Aging Services Programs; Deborah Britt, Executive Director of Community & Public Relations, Piedmont Fayette Hospital; Deena Chisolm, Associate Professor of Pediatrics & Public Health, The Ohio State University, Nationwide Children's Hospital; Robert Espinoza, Vice President of Policy, Paraprofessional Healthcare Institute; Louise Scherer Knight, Director, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Roanne Osborne- Gaskin, M.D., Senior Medical Director, MDWise, Inc.; Cathy Phan, Outreach and Education Coordinator, Asian American Health Coalition DBA HOPE Clinic; Kamilah Pickett, Litigation Support, Independent Contractor; Alvia Siddiqi, Medicaid Managed Care Community Network (MCCN) Medical Director, Advocate Physician Partners, Carla Smith, Executive Vice President, Healthcare Information and Management Systems Society (HIMSS); Tobin Van Ostern, Vice President and Co-Founder, Young Invincibles Advisors; and Paula Villescaz, Senior Consultant, Assembly Health Committee, California State Legislature. II. Provisions of This Notice In accordance with section 10(a) of the FACA, this notice announces a meeting of the APOE. The agenda for the March 21, 2018 meeting will include the following: Welcome and listening session with CMS leadership Recap of the previous (September 13, 2017) meeting CMS programs, initiatives, and priorities An opportunity for public comment Meeting summary, review of recommendations, and next steps Individuals or organizations that wish to make a 5-minute oral presentation on an agenda topic should submit a written copy of the oral presentation to the DFO at the address listed in the ADDRESSES section of this notice by the date listed in the DATES section of this notice. The number of oral presentations may be limited by the time available. Individuals not wishing to make an oral presentation may submit written comments to the DFO at the address listed in the ADDRESSES section of this notice by the date listed in the DATES section of this notice. III. Security Guidelines The meeting is open to the public, but attendance is limited to the space available. Persons wishing to attend this meeting must register by contacting the DFO at the address listed in the ADDRESSES section of this notice or by telephone at the number listed in the FOR FURTHER INFORMATION CONTACT section of this notice by the date specified in the DATES section of this notice. This meeting will be held in a federal government building, the Hubert H. Humphrey (HHH) Building; therefore, federal security measures are applicable. [[Page 8996]] The REAL ID Act of 2005 (Pub. L. 109-13) establishes minimum standards for the issuance of state-issued driver's licenses and identification (ID) cards. It prohibits federal agencies from accepting an official driver's license or ID card from a state for any official purpose unless the Secretary of the Department of Homeland Security determines that the state meets these standards. Beginning October 2015, photo IDs (such as a valid driver's license) issued by a state or territory not in compliance with the Real ID Act will not be accepted as identification to enter federal buildings. Visitors from these states/territories will need to provide alternative proof of identification (such as a valid passport) to gain entrance into federal buildings. The current list of states from which a federal agency may accept driver's licenses for an official purpose is found at http://www.dhs.gov/real-id-enforcement-brief. We recommend that confirmed registrants arrive reasonably early, but no earlier than 45 minutes prior to the start of the meeting, to allow additional time to clear security. Security measures include the following: Presentation of a government-issued photographic identification to the Federal Protective Service or Guard Service personnel. Inspection, via metal detector or other applicable means, of all persons entering the building. We note that all items brought into HHH Building, whether personal or for the purpose of presentation or to support a presentation, are subject to inspection. We cannot assume responsibility for coordinating the receipt, transfer, transport, storage, set up, safety, or timely arrival of any personal belongings or items used for presentation or to support a presentation. Note: Individuals who are not registered in advance will not be permitted to enter the building and will be unable to attend the meeting. Authority: 42 U.S.C. 217a, sec. 222 of the Public Health Service Act, as amended; 42 U.S.C. 1314(f), sec. 1114(f) of the Social Security Act; and Public Law 92-463, as amended (5 U.S.C. App. 2); 41 CFR 102-3. Dated: February 21, 2018. Seema Verma, Administrator, Centers for Medicare & Medicaid Services. [FR Doc. 2018-04328 Filed 3-1-18; 8:45 am] BILLING CODE 4120-01-P
![8994 Federal Register / Vol. 83, No. 42 / Friday, March 2, 2018 / Notices
The Patient Safety Act authorizes the DEPARTMENT OF HEALTH AND other special accommodations should
listing of PSOs, which are entities or HUMAN SERVICES contact the Acting DFO at the address
component organizations whose listed in the ADDRESSES section of this
mission and primary activity are to Centers for Medicare & Medicaid notice by the date listed in the DATES
conduct activities to improve patient Services section of this notice.
safety and the quality of health care [CMS–7049–N] FOR FURTHER INFORMATION CONTACT:
delivery. Lynne Johnson, Acting Designated
HHS issued the Patient Safety Rule to Medicare, Medicaid, and Other Federal Official, Office of
Programs, Initiatives, and Priorities; Communications, CMS, 7500 Security
implement the Patient Safety Act.
Meeting of the Advisory Panel on Boulevard, Mail Stop S1–05–06,
AHRQ administers the provisions of the
Outreach and Education (APOE), Baltimore, MD 21244–1850, 410–786–
Patient Safety Act and Patient Safety
March 21, 2018 0090, email Lynne.Johnson@
Rule relating to the listing and operation cms.hhs.gov. Additional information
of PSOs. The Patient Safety Rule AGENCY: Centers for Medicare & about the APOE is available on the
authorizes AHRQ to list as a PSO an Medicaid Services (CMS), HHS. internet at: http://www.cms.gov/
entity that attests that it meets the ACTION: Notice. Regulations-and-Guidance/Guidance/
statutory and regulatory requirements FACA/APOE.html. Press inquiries are
for listing. A PSO can be ‘‘delisted’’ if SUMMARY: This notice announces the
handled through the CMS Press Office
it is found to no longer meet the next meeting of the Advisory Panel on
at (202) 690–6145.
requirements of the Patient Safety Act Outreach and Education (APOE) (Panel)
in accordance with the Federal SUPPLEMENTARY INFORMATION:
and Patient Safety Rule, when a PSO
chooses to voluntarily relinquish its Advisory Committee Act. The Panel I. Background
advises and makes recommendations to
status as a PSO for any reason, or when The Advisory Panel for Outreach and
the Secretary of the U.S. Department of
a PSO’s listing expires. Section 3.108(d) Education (APOE) (Panel) is governed
Health and Human Services (HHS) and
of the Patient Safety Rule requires by the provisions of Federal Advisory
the Administrator of the Centers for
AHRQ to provide public notice when it Committee Act (FACA) (Pub. L. 92–
Medicare & Medicaid Services (CMS) on
removes an organization from the list of 463), as amended (5 U.S.C. Appendix 2),
opportunities to enhance the
federally approved PSOs. which sets forth standards for the
effectiveness of consumer education
formation and use of federal advisory
AHRQ has accepted a notification strategies concerning CMS programs,
committees. The Panel is authorized by
from the NCH Healthcare System, PSO, initiatives, and priorities. This meeting
section 1114(f) of the Social Security
a component entity of the NCH is open to the public.
Act (42 U.S.C. 1314(f)) and section 222
Healthcare System, PSO number P0191, DATES: of the Public Health Service Act (42
to voluntarily relinquish its status as a Meeting Date: Wednesday, March 21, U.S.C. 217a).
PSO. Accordingly, the NCH Healthcare 2018, 8:30 a.m. to 4:00 p.m. eastern The Secretary of the U.S. Department
System, PSO was delisted effective at daylight time (e.d.t.). of Health and Human Services (HHS)
12:00 Midnight ET (2400) on January 31, Deadline for Meeting Registration, (the Secretary) signed the charter
2018. Presentations, Special Accommodations establishing the Citizen’s Advisory
and Comments: Wednesday, March 7, Panel on Medicare Education 1 (the
The NCH Healthcare System, PSO has
2018, 5:00 p.m. eastern standard time predecessor to the APOE) on January 21,
patient safety work product (PSWP) in
(e.s.t.). 1999 (64 FR 7899, February 17, 1999) to
its possession. The PSO will meet the
requirements of section 3.108(c)(2)(i) of ADDRESSES: advise and make recommendations to
the Patient Safety Rule regarding Meeting Location: U.S. Department of the Secretary and the Administrator of
notification to providers that have Health & Human Services, Hubert H. the Centers for Medicare & Medicaid
reported to the PSO and of section Humphrey Building, 200 Independence Services (CMS) on the effective
Avenue SW, Room 505A, Conference implementation of national Medicare
3.108(c)(2)(ii) regarding disposition of
Room, Washington, DC 20201. education programs, including with
PSWP consistent with section
Presentations and Written Comments: respect to the Medicare+Choice (M+C)
3.108(b)(3). According to section program added by the Balanced Budget
Presentations and written comments
3.108(b)(3) of the Patient Safety Rule, Act of 1997 (Pub. L. 105–33).
should be submitted to: Lynne Johnson,
the PSO has 90 days from the effective The Medicare Modernization Act of
Acting Designated Federal Official
date of delisting and revocation to (DFO), Office of Communications, 2003 (MMA) (Pub. L. 108–173)
complete the disposition of PSWP that Centers for Medicare & Medicaid expanded the existing health plan
is currently in the PSO’s possession. Services, 7500 Security Boulevard, options and benefits available under the
More information on PSOs can be Mailstop S1–05–06, Baltimore, MD M+C program and renamed it the
obtained through AHRQ’s PSO website 21244–1850 or via email at Medicare Advantage (MA) program. We
at http://www.pso.ahrq.gov. Lynne.Johnson@cms.hhs.gov. have had substantial responsibilities to
Registration: The meeting is open to provide information to Medicare
Karen J. Migdail, the public, but attendance is limited to beneficiaries about the range of health
Chief of Staff. the space available. Persons wishing to plan options available and better tools
[FR Doc. 2018–04217 Filed 3–1–18; 8:45 am] attend this meeting must register at the to evaluate these options. The
daltland on DSKBBV9HB2PROD with NOTICES
BILLING CODE 4160–90–P website https://www.regonline.com/ successful MA program implementation
apoemar2018meeting or by contacting required CMS to consider the views and
the Acting DFO as listed in the FOR
1 We note that the Citizen’s Advisory Panel on
FURTHER INFORMATION CONTACT section of
Medicare Education is also referred to as the
this notice, by the date listed in the Advisory Panel on Medicare Education (65 FR
DATES section of this notice. Individuals 4617). The name was updated in the Second
requiring sign language interpretation or Amended Charter approved on July 24, 2000.
VerDate Sep<11>2014 18:10 Mar 01, 2018 Jkt 244001 PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 E:\FR\FM\02MRN1.SGM 02MRN1](https://thefederalregister.org/doc/83_FR_9036/page/1.svg)
![8996 Federal Register / Vol. 83, No. 42 / Friday, March 2, 2018 / Notices
The REAL ID Act of 2005 (Pub. L. DEPARTMENT OF HEALTH AND • Mail/Hand delivery/Courier (for
109–13) establishes minimum standards HUMAN SERVICES written/paper submissions): Dockets
for the issuance of state-issued driver’s Management Staff (HFA–305), Food and
licenses and identification (ID) cards. It Food and Drug Administration Drug Administration, 5630 Fishers
prohibits federal agencies from Lane, Rm. 1061, Rockville, MD 20852.
[Docket No. FDA–2006–P–0207] • For written/paper comments
accepting an official driver’s license or
ID card from a state for any official Proper Labeling of Honey and Honey submitted to the Dockets Management
purpose unless the Secretary of the Products; Guidance for Industry; Staff, FDA will post your comment, as
Department of Homeland Security Availability well as any attachments, except for
determines that the state meets these information submitted, marked and
standards. Beginning October 2015, AGENCY: Food and Drug Administration, identified, as confidential, if submitted
photo IDs (such as a valid driver’s HHS. as detailed in ‘‘Instructions.’’
license) issued by a state or territory not ACTION: Notice of availability. Instructions: All submissions received
in compliance with the Real ID Act will must include the Docket No. FDA–
SUMMARY: The Food and Drug 2006–P–0207 for ‘‘Proper Labeling of
not be accepted as identification to enter Administration (FDA or we) is Honey and Honey Products.’’ Received
federal buildings. Visitors from these announcing the availability of a comments will be placed in the docket
states/territories will need to provide guidance for industry entitled ‘‘Proper and, except for those submitted as
alternative proof of identification (such Labeling of Honey and Honey ‘‘Confidential Submissions,’’ publicly
as a valid passport) to gain entrance into Products.’’ The guidance advises firms viewable at https://www.regulations.gov
federal buildings. The current list of on the proper labeling of honey and or at the Dockets Management Staff
states from which a federal agency may honey products to help ensure that between 9 a.m. and 4 p.m., Monday
accept driver’s licenses for an official honey and honey products are not through Friday.
purpose is found at http://www.dhs.gov/ adulterated or misbranded under the • Confidential Submissions—To
real-id-enforcement-brief. Federal Food, Drug, and Cosmetic Act. submit a comment with confidential
We recommend that confirmed DATES: The announcement of the information that you do not wish to be
registrants arrive reasonably early, but guidance is published in the Federal made publicly available, submit your
no earlier than 45 minutes prior to the Register on March 2, 2018. comments only as a written/paper
start of the meeting, to allow additional ADDRESSES: You may submit either submission. You should submit two
time to clear security. Security measures electronic or written comments on copies total. One copy will include the
include the following: Agency guidances at any time as information you claim to be confidential
follows: with a heading or cover note that states
• Presentation of a government-issued ‘‘THIS DOCUMENT CONTAINS
photographic identification to the Electronic Submissions CONFIDENTIAL INFORMATION.’’ We
Federal Protective Service or Guard Submit electronic comments in the will review this copy, including the
Service personnel. following way: claimed confidential information, in our
• Inspection, via metal detector or • Federal eRulemaking Portal: consideration of comments. The second
other applicable means, of all persons https://www.regulations.gov. Follow the copy, which will have the claimed
entering the building. We note that all instructions for submitting comments. confidential information redacted/
items brought into HHH Building, Comments submitted electronically, blacked out, will be available for public
whether personal or for the purpose of including attachments, to https:// viewing and posted on https://
presentation or to support a www.regulations.gov will be posted to www.regulations.gov. Submit both
presentation, are subject to inspection. the docket unchanged. Because your copies to the Dockets Management Staff.
We cannot assume responsibility for comment will be made public, you are If you do not wish your name and
coordinating the receipt, transfer, solely responsible for ensuring that your contact information to be made publicly
transport, storage, set up, safety, or comment does not include any available, you can provide this
confidential information that you or a information on the cover sheet and not
timely arrival of any personal
third party may not wish to be posted, in the body of your comments and you
belongings or items used for
such as medical information, your or must identify this information as
presentation or to support a ‘‘confidential.’’ Any information marked
presentation. anyone else’s Social Security number, or
confidential business information, such as ‘‘confidential’’ will not be disclosed
Note: Individuals who are not registered in as a manufacturing process. Please note except in accordance with 21 CFR 10.20
advance will not be permitted to enter the that if you include your name, contact and other applicable disclosure law. For
building and will be unable to attend the information, or other information that more information about FDA’s posting
meeting. identifies you in the body of your of comments to public dockets, see 80
comments, that information will be FR 56469, September 18, 2015, or access
Authority: 42 U.S.C. 217a, sec. 222 of the the information at: https://www.gpo.gov/
posted on https://www.regulations.gov.
Public Health Service Act, as amended; 42
• If you want to submit a comment fdsys/pkg/FR-2015-09-18/pdf/2015-
U.S.C. 1314(f), sec. 1114(f) of the Social 23389.pdf.
with confidential information that you
Security Act; and Public Law 92–463, as
do not wish to be made available to the Docket: For access to the docket to
amended (5 U.S.C. App. 2); 41 CFR 102–3.
public, submit the comment as a read background documents or the
daltland on DSKBBV9HB2PROD with NOTICES
Dated: February 21, 2018. written/paper submission and in the electronic and written/paper comments
Seema Verma, manner detailed (see ‘‘Written/Paper received, go to https://
Administrator, Centers for Medicare & Submissions’’ and ‘‘Instructions’’). www.regulations.gov and insert the
Medicaid Services. docket number, found in brackets in the
Written/Paper Submissions heading of this document, into the
[FR Doc. 2018–04328 Filed 3–1–18; 8:45 am]
Submit written/paper submissions as ‘‘Search’’ box and follow the prompts
BILLING CODE 4120–01–P
follows: and/or go to the Dockets Management
VerDate Sep<11>2014 18:10 Mar 01, 2018 Jkt 244001 PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 E:\FR\FM\02MRN1.SGM 02MRN1](https://thefederalregister.org/doc/83_FR_9036/page/3.svg)
Document Created: 2018-03-01 23:56:39
Document Modified: 2018-03-01 23:56:39
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice. | |
| Dates | Meeting Date: Wednesday, March 21, 2018, 8:30 a.m. to 4:00 p.m. eastern daylight time (e.d.t.). | |
| Contact | Lynne Johnson, Acting Designated Federal Official, Office of Communications, CMS, 7500 Security Boulevard, Mail Stop S1-05-06, Baltimore, MD 21244-1850, 410-786-0090, email [email protected] Additional information about the APOE is available on the internet at: http://www.cms.gov/Regulations-and- Guidance/Guidance/FACA/APOE.html. Press inquiries are handled through the CMS Press Office at (202) 690-6145. | |
| FR Citation | 83 FR 8994 |
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR